AP
SILK

Archon Partners’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Archon Partners’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-66,100
Closed -$3.2M – 59
2019
Q2 		$3.2M Buy
+66,100
New +$2.81M 0.64% 40

Other funds holding SILK

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Archon Partners's SILK Position: Q3 2019 in Review

Archon Partners sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2019, closing a stake of 66,100 shares — an estimated $3.2M sold.

Archon Partners first reported a position in SILK in Q2 2019 and held it in 1 quarter. The position peaked at $3.2M in Q2 2019. 101 funds tracked by Wall St. Rank hold SILK as of Q3 2019.

  • Archon Partners reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Archon Partners sold 66,100 Silk Road Medical, Inc. Common Stock shares in Q3 2019, an estimated $3.2M.
  • Archon Partners first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Archon Partners's Silk Road Medical, Inc. Common Stock position peaked at $3.2M in Q2 2019.
  • 101 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2019.

Based on Archon Partners's 13F filing for Q3 2019, filed 14 Nov 2019.